Greenpro Capital Corp. announced the spin-off of 5.8% stake in DSwiss, Inc. for approximately MYR 420 million.
August 17, 2020
Share
Greenpro Capital Corp. (NasdaqCM:GRNQ) announced the spin-off of 5.8% stake in DSwiss, Inc. (OTCPK:DQWS) for approximately MYR 420 million on August 18, 2020. Under the spin-off, one share of DSwiss common stock for approximately every 5 shares of Greenpro Capital Corp.
common stock issued and outstanding will be distributed on the record date. DSwiss plans to apply to up-list to a main board stock exchange in 2021. Greenpro Capital will distribute 12 million shares of common stock of D'Swiss, Inc. to Greenpro Capital shareholders of record on September 30, 2020.
Greenpro owns a total of 27 million shares of DSwiss.
DSwiss, Inc. is a biotech nutraceutical company that offers healthcare, skincare, and personal care products. The Company sells medical consumable supplies, food supplements, skincare, and other related beauty products in Malaysia and around the ASEAN region. The Company is a turnkey private label manufacturing services provider for nutraceutical and skincare/personal care original design manufacturer (ODM)/ original equipment manufacturer (OEM) products. It provides ODM/OEM services ranging from research and development of custom formulation, manufacturing and production, packaging and shipping including import and export and all licenses needed. It also provides lab testing and quality control services. Its products and formulations include functional food, skincare, personal care and pet-care. Its personal care products include cosmetics, shower gel and lotion. It provides food supplement in different forms such as chewable tablets, jellies, teabags, capsules and gummies.
DSWISS, INC. 
